Sat.Jan 06, 2024 - Fri.Jan 12, 2024

article thumbnail

The Political Theater Of Importing Prescription Drugs From Canada

Forbes: Drug Truths

The FDA had been previously reluctant to approve such a plan for safety concerns.

FDA 249
article thumbnail

The science of ageing and restoring healthspan

Drug Target Review

What is “healthspan” and how does it relate to Life Bioscience’s mission? It is no mystery that as we age our health starts to deteriorate, and we become increasingly susceptible to diseases. If we take into consideration the timeframe of our lives, our “healthspan” is defined as the number of healthy years we live, which is different than our lifespan, the number of years of life.

Science 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scientists identify how dietary restriction slows brain aging and increases lifespan

Science Daily: Pharmacology News

Restricting calories is known to improve health and increase lifespan, but much of how it does so remains a mystery, especially in regard to how it protects the brain. Scientists have now uncovered a role for a gene called OXR1 that is necessary for the lifespan extension seen with dietary restriction and is essential for healthy brain aging.

141
141
article thumbnail

A 'Universal' COVID Vaccine Could Save Billions If Another Pandemic Strikes

Drugs.com

FRIDAY, Jan. 12, 2024 -- A universal coronavirus vaccine could have saved millions of lives and billions of dollars if one had been available prior to the pandemic, a new study argues. Further, a universal vaccine -- one that targets parts of the.

Vaccine 137
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Addgene is Stopping Use of X (formerly Twitter)

addgene Blog

Addgene is announcing we have chosen to stop all activity on X, formerly Twitter. If you are interested in engaging with us on social media, you can find us on Bluesky: @addgene.bsky.social; or @addgene on Instagram, TikTok, Facebook, and LinkedIn. We are also exploring other social media platforms with active scientific communities and welcome suggestions in the comments.

127
127
article thumbnail

Living with PSC: What to know about primary sclerosing cholangitis

Antidote

An estimated 1 in 10,000 people have primary sclerosing cholangitis (PSC) , a condition that impacts the bile ducts that run between the liver, the gallbladder, and the small intestine. The liver produces bile to transport to the gallbladder for storage, or to the small intestine where it aids in the digestion of fats. In the case of PSC, there is inflammation in the bile ducts (cholangitis) which leads to scarring (sclerosis) that narrows the ducts.

122
122

More Trending

article thumbnail

COVID Can Threaten Sickle Cell Patients, But Too Few Are Vaccinated

Drugs.com

FRIDAY, Jan. 12, 2024 -- Sickle cell disease is one of many chronic health conditions that dramatically increases the risk of hospitalization and death in people infected by COVID-19.Unfortunately, folks with sickle cell disease are much less.

Vaccine 141
article thumbnail

Backed by billionaires, a new biomedical institute tests an unorthodox approach

BioPharma Drive: Drug Pricing

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

article thumbnail

Biotech Venture Ecosystem: Quick Health Check

LifeSciVC

Biotech feels like it’s got some wind in its sails here at the start of 2024, with positive sentiments from the JPM conference. Indeed, the public equity markets feeling somewhat buoyant for the first time in ages. With the close out of 2023, it’s time to take stock of the health of the private venture ecosystem. Analyzing Pitchbook data for venture funding into US-based biopharma companies, at least four themes are worth highlighting related to overall funding, startup creation, mega-rounds, an

Marketing 113
article thumbnail

Solid state battery design charges in minutes, lasts for thousands of cycles

Science Daily: Pharmacology News

Researchers have developed a new lithium metal battery that can be charged and discharged at least 6,000 times -- more than any other pouch battery cell -- and can be recharged in a matter of minutes. The research not only describes a new way to make solid state batteries with a lithium metal anode but also offers new understanding into the materials used for these potentially revolutionary batteries.

Research 126
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Court Ruling Could Bring Higher Patient Costs for PrEP, and More HIV Infections

Drugs.com

TUESDAY, Jan. 9, 2024 -- HIV pre-exposure prophylaxis (PrEP) is a lifeline for Americans, many of them gay men, who are at high risk of contracting the virus that causes AIDS.But a case that is winding its way through the court system might push.

Virus 119
article thumbnail

JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform

BioPharma Drive: Drug Pricing

Albert Bourla acknowledged Pfizer’s difficult 2023, while a biotech CEO spoke with BioPharma Dive about building neuroscience startups.

127
127
article thumbnail

How AI is accelerating the future of precision medicine

Drug Target Review

How does the integration of Real-World Data (RWD) with genomic biomarker data contribute to a more comprehensive understanding of disease progression and treatment response? Most drugs do not work in all people. This one size fits all approach to drug prescribing still pervades in mostly all therapy areas except oncology. So, knowing an individual and something about their profile, whether that be biomarkers such as genomic data, blood-based markers or even transcriptomics of tissues or blood, p

Doctors 111
article thumbnail

Medical Device Industry Trends for 2024

Perficient: Drug Development

Medical device industry trends for 2024. The medical device industry is in a constant state of evolution. We are seeing more sophisticated consumer expectations, advancements in technology, regulatory changes, and changing healthcare needs – just to name a few. As we gaze into our crystal ball, five key trends have bubbled up. Let’s look at what is poised to impact the medical device industry in 2024.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Overuse of Antifungal Skin Meds Could Be Driving Drug-Resistant Disease

Drugs.com

THURSDAY, Jan. 11, 2024 -- U.S. doctors are prescribing antifungal creams to patients with skin complaints at rates so high they could be contributing to the rise of drug-resistant infections, new research shows.These are "severe.

Doctors 116
article thumbnail

JPM24: Nvidia’s AI dreams, Sarepta’s rosy outlook and Jeff Jonas’ new job

BioPharma Drive: Drug Pricing

The chip maker struck a new deal with Amgen on Monday, while Sarepta brought news of strong sales to the J.P. Morgan Healthcare Conference.

127
127
article thumbnail

Unique self-activating proteins for drug discovery

Drug Target Review

In this eBook, we explore how researchers identified two unique proteins within N. fowleri – self-activating guanine nucleotide-hydrolysing proteins (G proteins) – that present novel targets for drug discovery. This article summarises their work to date, including a high-throughput fluorescence assay of guanine nucleotide hydrolysis for rapid But that’s not all.

Drugs 111
article thumbnail

Catalytic combo converts CO2 to solid carbon nanofibers

Science Daily: Pharmacology News

Scientists have developed a way to convert carbon dioxide (CO2), a potent greenhouse gas, into carbon nanofibers, materials with a wide range of unique properties and many potential long-term uses. Their strategy uses tandem electrochemical and thermochemical reactions run at relatively low temperatures and ambient pressure and could successfully lock carbon away to offset or even achieve negative carbon emissions.

126
126
article thumbnail

Quaker Oats Widens Recall of Granola Bars, Cereals Linked to Salmonella Risk

Drugs.com

FRIDAY, Jan. 12, 2024 -- The Quaker Oats Co has widened a recall of granola bars and cereals that was first announced in December, adding more products that may potentially be contaminated with salmonella.The products were sold in all U.S. states.

article thumbnail

5 questions facing pharma in 2024

BioPharma Drive: Drug Pricing

Many drugmakers hope to compete in obesity, while others seek to win oncology’s next era. In the background, a contentious drug pricing law looms.

Drugs 120
article thumbnail

Patient Perspectives: After a lung cancer diagnosis, turning to art and medical research

Antidote

One of the most important results of the work we do at Antidote is directly impacting the lives of patients — and getting to hear their stories is a constant reminder of why we do what we do.

Research 105
article thumbnail

Optimizely CMS – Working with special symbols in TinyMCE

Perficient: Drug Development

If you’ve worked with Optimizely CMS, you might be pretty familiar with TinyMCE. Its the amazing rich text editor that works seamlessly with Optimizely CMS. And some of you may have worked with some or other form of customization with it in projects, be it adding additional styles, work with different plugins, format the toolbar to suit your clients’ requirements and more.

105
105
article thumbnail

FDA to Import Syphilis Drug, Extencilline, From France Amid Shortage

Drugs.com

THURSDAY, Jan. 11, 2024 -- Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker. In a.

FDA 111
article thumbnail

Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi

BioPharma Drive: Drug Pricing

At the J.P. Morgan Healthcare Conference Monday, company head Chris Viehbacher said insurance reimbursement is now ‘not an issue’ for treatment.

Treatment 112
article thumbnail

A Guide to DNA Damage Response and Innate Immunity

Drug Target Review

There is extensive crosstalk between the DNA damage response (DDR) and innate immune pathways. Both are a focus for exciting new small-molecule drug therapeutics that target cancers and autoimmune disorders. The Transcreener HTS Assay platform accelerates these efforts by providing robust and easy-to-use biochemical assays for key enzymes in the pathways.

DNA 104
article thumbnail

A beating biorobotic heart aims to better simulate valves

Science Daily: Pharmacology News

Combining a biological heart and a silicone robotic pump, researchers created a biorobotic heart that beats like a real one, with a focus on a valve on the left side of the heart. The heart valve simulator can mimic the structure, function, and motion of a healthy or diseased heart, allowing surgeons and researchers to demonstrate various interventions while collecting real-time data.

Disease 122
article thumbnail

One Liter of Bottled Water Contains 240,000 Tiny Bits of Plastic

Drugs.com

MONDAY, Jan. 8, 2024 -- Folks quenching their thirst with bottled water can expect to chug down hundreds of thousands of minute plastic particles with their refreshing H2O, a new study reports.On average, a liter of bottled water contains some.

105
105
article thumbnail

Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence

Drug Channels

Today’s guest post comes from Maria Kirsch, President, Patient Services, Krista Pinto, President, Deployment Solutions, and Mike Scott, Senior Vice President, Specialty Consulting at EVERSANA. Maria, Krista, and Mike discuss the key reasons why patients abandon drug therapy. They then describe EVERSANA’s approach for helping manufacturers and healthcare providers improve adherence and health outcomes.

article thumbnail

PEAR-TREE: Understanding the usefulness of the PEAR-BIO platform in patients with kidney cancer

On Medicine

Kidney cancer poses a significant healthcare burden in the UK, with 13,000 new patients diagnosed annually, a 52% survival rate, and nearly 5,000 patients dying each year. The US faces similar problems, with 81,000 new cases and nearly 14,000 deaths annually. The incidence of renal cell carcinoma (RCC) has more than doubled in the last 50 years and is increasing by 2-3% every year.

article thumbnail

Evolution is not as random as previously thought

Science Daily: Pharmacology News

A groundbreaking study has found that evolution is not as unpredictable as previously thought, which could allow scientists to explore which genes could be useful to tackle real-world issues such as antibiotic resistance, disease and climate change. The study challenges the long-standing belief about the unpredictability of evolution, and has found that the evolutionary trajectory of a genome may be influenced by its evolutionary history, rather than determined by numerous factors and historical

Disease 109
article thumbnail

Paxlovid Won't Cut Odds for Long COVID: Study

Drugs.com

MONDAY, Jan. 8, 2024 -- Paxlovid might help shorten and diminish a COVID infection, but the antiviral doesn’t reduce the risk of developing long COVID, a new study shows.About 16% of COVID patients treated with Paxlovid wound up with long COVID.

115
115
article thumbnail

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup

Drug Channels

For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. You can find our updated counting below. This year, Humira and its 13 biosimilars will provide the most intriguing formulary drama. Unfortunately, the gross-to-net bubble will remain a fixture for this category, despite a price war led by almost half of the biosimilars.

article thumbnail

Merck pays $680M for struggling cancer biotech Harpoon

BioPharma Drive: Drug Pricing

The acquisition will build out Merck’s pipeline of immunotherapies as its top-seller Keytruda nears the end of U.S. market exclusivity.

Marketing 109
article thumbnail

Record heat in 2023 worsened global droughts, floods and wildfires

Science Daily: Pharmacology News

Record heat across the world profoundly impacted the global water cycle in 2023, contributing to severe storms, floods, megadroughts and bushfires, new research shows.

Research 125